391 related articles for article (PubMed ID: 27580464)
21. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
22. The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita.
Marzano AV; Cozzani E; Biasin M; Russo I; Alaibac M
Arch Dermatol Res; 2016 May; 308(4):273-6. PubMed ID: 26895535
[TBL] [Abstract][Full Text] [Related]
23. Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University.
Hashimoto T; Jin Z; Ishii N
Expert Rev Clin Immunol; 2016 Aug; 12(8):895-902. PubMed ID: 27247994
[TBL] [Abstract][Full Text] [Related]
24. Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita.
Komorowski L; Müller R; Vorobyev A; Probst C; Recke A; Jonkman MF; Hashimoto T; Kim SC; Groves R; Ludwig RJ; Zillikens D; Stöcker W; Schmidt E
J Am Acad Dermatol; 2013 Mar; 68(3):e89-95. PubMed ID: 22341608
[TBL] [Abstract][Full Text] [Related]
25. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita.
Woodley DT; Chang C; Saadat P; Ram R; Liu Z; Chen M
J Invest Dermatol; 2005 May; 124(5):958-64. PubMed ID: 15854036
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and clinical features of epidermolysis bullosa acquisita.
Caux F
Dermatol Clin; 2011 Jul; 29(3):485-91, x. PubMed ID: 21605816
[TBL] [Abstract][Full Text] [Related]
27. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo.
Recke A; Trog LM; Pas HH; Vorobyev A; Abadpour A; Jonkman MF; van Zandbergen G; Kauderer C; Zillikens D; Vidarsson G; Ludwig RJ
J Immunol; 2014 Aug; 193(4):1600-8. PubMed ID: 25024393
[TBL] [Abstract][Full Text] [Related]
29. Epidermolysis bullosa acquisita.
Gupta R; Woodley DT; Chen M
Clin Dermatol; 2012; 30(1):60-9. PubMed ID: 22137228
[TBL] [Abstract][Full Text] [Related]
30. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
Remington J; Chen M; Burnett J; Woodley DT
Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
[TBL] [Abstract][Full Text] [Related]
31. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita.
Koga H; Teye K; Yamashita K; Ishii N; Tsuruta D; Nakama T
Br J Dermatol; 2019 May; 180(5):1107-1113. PubMed ID: 30311191
[TBL] [Abstract][Full Text] [Related]
32. Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies.
Wakelin SH; Bhogal B; Black MM; Allen J; Wojnarowska F; Hashimoto T; Farr PM; Swain AF
Br J Dermatol; 1997 Apr; 136(4):604-9. PubMed ID: 9155969
[TBL] [Abstract][Full Text] [Related]
33. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
Woodley DT; Remington J; Chen M
Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):78-84. PubMed ID: 18058258
[TBL] [Abstract][Full Text] [Related]
34. [Epidermolysis bullosa acquisita].
Hofmann SC; Weidinger A
Hautarzt; 2019 Apr; 70(4):265-270. PubMed ID: 30887080
[TBL] [Abstract][Full Text] [Related]
35. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
[TBL] [Abstract][Full Text] [Related]
36. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.
Hammers CM; Bieber K; Kalies K; Banczyk D; Ellebrecht CT; Ibrahim SM; Zillikens D; Ludwig RJ; Westermann J
J Immunol; 2011 Nov; 187(10):5043-50. PubMed ID: 21967893
[TBL] [Abstract][Full Text] [Related]
37. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita.
Ludwig RJ; Müller S; Marques Ad; Recke A; Schmidt E; Zillikens D; Möller S; Ibrahim SM
J Invest Dermatol; 2012 May; 132(5):1409-15. PubMed ID: 22297639
[TBL] [Abstract][Full Text] [Related]
38. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.
Kim JH; Kim YH; Kim S; Noh EB; Kim SE; Vorobyev A; Schmidt E; Zillikens D; Kim SC
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e224-30. PubMed ID: 22731917
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.
Ishii N; Recke A; Mihai S; Hirose M; Hashimoto T; Zillikens D; Ludwig RJ
J Pathol; 2011 Jun; 224(2):234-44. PubMed ID: 21381035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
